Type II Diabetes Mellitus
1 competing product in clinical development for Type II Diabetes Mellitus.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Daily injection of KBP/placebo for up to 28 days | Eli Lilly | Phase 1 | Terminated | 33 |